Biotech booming in Belgium

Tweet
Facebook
LinkedIn
Google plus
Send to

Research undertaken by clinical research organisation Chiltern International into the market opportunities in Belgium, has concluded that Belgian biotechnology companies and university centres specialising in research are among the leaders in their sector, which saw turnover in Belgium rise by more than 30% during 2002. In addition, Belgium's central position within the EU has allowed the country to succeed in attracting considerable levels of investment. It is estimated that more than 100 companies in Belgium are involved with the biotechnology sector, and just under 80% of these are focused around healthcare. There are also a number of large pharmaceutical players present who have pioneered scientific research in the country. Chiltern International business development executive Dr Hannah Taylor conducted a research project into the market recently, and established links with a number of pharmaceutical and biotechnology companies, as well as visiting a variety of companies around the Brussels region. Chiltern International is a mid-sized clinical research organisation specialising in the global pharmaceutical and biotechnology industries.